Catalyst Wire Dossier Catalyst Wire Dossier

Novartis Exforge 10/160mg

amlodipine/valsartan · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novartis Exforge 10/160mg, covering 2012-05-01 to 2012-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg [Phase 1]

See pricing